Cintas (CTAS) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
15 Sep, 2026Executive summary
Fiscal 2026 saw record revenue of $11.26 billion, 8.9% growth, and all-time high gross margin of 50.7%.
Operating income rose to $2.61 billion (23.1% of revenue), and diluted EPS increased 11.6% to $4.91.
Adjusted EPS (excluding UniFirst acquisition costs) was $4.94, up 12.3% year-over-year.
$1.7 billion was returned to shareholders via buybacks and dividends.
Strategic focus includes technology investments, operational excellence, and a pending acquisition of UniFirst.
Voting matters and shareholder proposals
Shareholders will vote on: election of eight directors, advisory approval of executive compensation, ratification of Ernst & Young LLP as auditor, reincorporation from Washington to Delaware, and a shareholder proposal on majority voting governance.
Board recommends FOR all management proposals and AGAINST the shareholder proposal.
Board of directors and corporate governance
Eight director nominees, including a mix of independent and executive members, are proposed for one-year terms.
Board leadership is split between Executive Chairman and CEO; a Lead Director presides over independent sessions.
Board committees (Audit, Compensation, Nominating/Governance) are composed entirely of independent directors.
Board regularly reviews strategy, risk, and succession planning.
Latest events from Cintas
- Virtual annual meeting to vote on directors, pay, auditor, reincorporation, and governance.CTAS
Proxy filing - Record growth, Delaware reincorporation, and strong governance highlight this year's proxy.CTAS
Proxy filing - Record revenue and margin growth in 2026; strong 2027 outlook with continued investment.CTAS
Q4 2026 - Record revenue, margin highs, and raised guidance driven by broad-based growth and strong retention.CTAS
Q2 2026 - Q1 revenue and net income rose 8.7%, with raised guidance and strong share repurchases.CTAS
Q1 2026 - Revenue and net income surged, margins expanded, and guidance was raised for the full year.CTAS
Q2 2025 - Revenue and profit surged, margins expanded, and guidance was raised amid strong capital returns.CTAS
Q1 2025 - Record growth, margin expansion, and a four-for-one stock split set the stage for 2025.CTAS
Q4 2024 - Q3 revenue and EPS surged, driving higher guidance and robust margin expansion.CTAS
Q3 2025